Amneal Pharmaceuticals Inc. (AMRX)
Amneal Pharmaceuticals, Inc. - Amneal Announces Additional Positive Interim Phase 4 ELEVATE-PD Results withCREXONT® for Parkinson’s Disease, Including Over 3 More Hours of Daily “Good On” Time When Switching fromRYTARY®
📈 **POSITIVE** • Medium confidence analysis (69%) • Strong positive catalyst • High growth potential **Sentiment:** Positive (95%) **Content type:** General